September 2, 2014

Miami-Dade Business Profile

Biscayne Pharmaceuticals

| 8/14/2013
Samuel Reich and Andrew Schally (sitting)
Samuel Reich (standing) and Andrew Schally

For more than half a century, Nobel Prize-winning scientist and University of Miami faculty member Andrew Schally has been researching the hormones that stimulate growth in the body’s tissues. Now his work is being used by Miami-based Biscayne Pharmaceuticals, which was founded last year and licensed from UM the rights to Schally’s inventions related to that research. The company, which Schally works with as scientific adviser, is using his discovery to develop possible treatments for cancer and heart disease.

Biscayne Pharma got going after a $1.5-million investment from its co-founders and Miami Beach investment firm Reich Group, whose Managing Partner Samuel Reich joined Biscayne Pharma as CEO. “This is a breakthrough that will really transform the way we treat cancer,” Reich says.

Tags: Miami-Dade, Healthcare, Technology/Innovation

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single ditgital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Disney's Hoop-Dee-Doo still serving up laughs, dinner after 40 years
Disney's Hoop-Dee-Doo still serving up laughs, dinner after 40 years

The Hoop-Dee-Doo Musical Revue will mark its 40th anniversary this week after more than 37,000 dinner-show performances at Pioneer Hall, tucked away in Disney's Fort Wilderness campground.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Is it time to cash out of stocks?

  • Yes
  • Maybe - need to understand market dynamics better
  • No

See Results

Ballot Box
Subscribe